NPI: 1194083824 · MISSION HILLS, CA 91345 · Ambulatory Surgical Clinic/Center · NPI assigned 05/01/2012
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS) |
| Parent Organization | FACEY MEDICAL FOUNDATION |
| NPI Enumeration Date | 05/01/2012 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 155 | $0.00 |
| 2021 | 7,994 | $11K |
| 2022 | 11,586 | $6K |
| 2023 | 282 | $0.00 |
| 2024 | 82 | $0.00 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7,841 | 7,490 | $5K |
| 90686 | 1,364 | 1,364 | $5K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,179 | 2,142 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 43 | 42 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 573 | 572 | $1K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 207 | 207 | $548.91 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 43 | 42 | $525.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 36 | 23 | $457.90 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 99 | 98 | $301.79 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 478 | 450 | $173.34 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 475 | 473 | $133.95 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,223 | 1,213 | $13.98 |
| G9920 | Screening performed and negative | 2,192 | 2,178 | $9.00 |
| 11721 | 219 | 219 | $0.00 | |
| 99173 | 934 | 934 | $0.00 | |
| 3078F | 279 | 272 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 16 | 16 | $0.00 |
| 81003 | 15 | 14 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 13 | 13 | $0.00 |
| 0071A | 39 | 39 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 32 | 16 | $0.00 |
| 99215 | Prolong outpt/office vis | 12 | 12 | $0.00 |
| 92551 | 1,002 | 1,002 | $0.00 | |
| 85018 | 183 | 183 | $0.00 | |
| 1125F | 12 | 12 | $0.00 | |
| 3074F | 17 | 17 | $0.00 | |
| 1036F | 64 | 64 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 432 | 424 | $0.00 |
| 0072A | 16 | 16 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 13 | 13 | $0.00 |
| H0049 | Alcohol and/or drug screening | 12 | 12 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 12 | 12 | $0.00 |
| 96127 | 12 | 12 | $0.00 | |
| 90694 | 12 | 12 | $0.00 |